Predictors of Early and Late Mortality after Transcatheter Aortic Valve Implantation: A Multicenter Retrospective Chinese Study
Open Access
- 1 July 2023
- journal article
- Published by Medknow in Annals of Clinical Cardiology
- Vol. 5 (2) , 69-74
Abstract
Background: Patients undergoing TAVR constitute a high-risk population given their comorbidities and out-of-hospital mortality rates remain high despite significant improvements in the overall procedural outcomes. Objectives: The objective of this study was to determine the early and late mortality rates following transfemoral transcatheter aortic valve replacement (TAVR) and identify the risk factors for poor outcomes. Methods: This study population examined patients extracted from 43 publicly funded hospitals in Hong Kong between 2010 and 2019. The study constitutes retrospective analysis of mortality outcomes for severe aortic stenosis patients undergoing TAVR. The primary end points include out-of-hospital 30-day, 1-year, 1–2-year, and 2–5-year mortality rates. Results: A total of 448 patients underwent TAVR and were included into the study. The rates of mortality following TAVR were 1.7%, 3.3%, 1.3%, and 0.22% at 30 days, 1, 1–2, and 2–5 years, respectively. Age and chronic renal failure (CRF) were concluded to be associated with postprocedural mortality. Further analysis of the baseline echocardiographic parameters revealed a higher prevalence of right atrial enlargement (RAE) and tricuspid and pulmonary regurgitation in the deceased subgroup. Conclusion: We report the 30-day, 1-, 1–2-, and 2–5-year all-cause mortality for TAVR of 1.7%, 3.3%, 1.3%, and 0.22% at 30 days. Factors associated with a higher prevalence of mortality include age, CRF, RAE, and tricuspid and pulmonary regurgitation.Keywords
This publication has 28 references indexed in Scilit:
- Pulmonary Hypertension and Aortic StenosisJACC, 2022
- Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve ReplacementJACC, 2022
- Change in Kidney Function and 2-Year Mortality After Transcatheter Aortic Valve ReplacementJAMA Network Open, 2021
- TAVR Versus SAVR in Aortic StenosisJACC, 2021
- Evaluating Out-of-Hospital 30-Day Mortality After Transfemoral Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2021
- Out-of-Hospital Mortality Following TAVRJACC: Cardiovascular Interventions, 2021
- Association of Tricuspid Regurgitation With Transcatheter Aortic Valve Replacement Outcomes: A Report From The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy RegistryThe Annals of Thoracic Surgery, 2018
- Quality-of-Life Outcomes After Transcatheter Aortic Valve Replacement in an Unselected PopulationJAMA Cardiology, 2017
- Impact of frailty on mortality after transcatheter aortic valve implantationAmerican Heart Journal, 2017
- Transcatheter Aortic Valve Implantation for the Treatment of Severe Symptomatic Aortic Stenosis in Patients at Very High or Prohibitive Surgical RiskJACC, 2010